General Information of This Metabolic Reaction (MR) (ID:
MR001972) |
Formula |
|
Reactant |
Pentamidine isethionate |
Product |
Pentamidine Amidoxime |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Lauric acid omega-hydroxylase (CYP4A11)
|
DME Info
|
Cytochrome P450 1A1 (CYP1A1)
|
DME Info
|
Cytochrome P450 1A1 (CYP1A1)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol. 2003 Sep;59(5-6):429-42.
|
2 |
Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration. Clin Transplant. 2011 May-Jun;25(3):E271-5.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.